Reversible	reversible	O	O
dilated	dilated	O	B_disease
cardiomyopathy	cardiomyopathy	O	S_disease
related	related	O	O
to	to	O	O
amphotericin	amphotericin	O	O
B	b	O	O
therapy	therapy	O	O
.	.	O	O

We	we	O	O
describe	describe	O	O
a	a	O	O
patient	patient	O	O
who	who	O	O
developed	developed	O	O
dilated	dilated	O	B_disease
cardiomyopathy	cardiomyopathy	O	S_disease
and	and	O	O
clinical	clinical	O	O
congestive	congestive	O	B_disease
heart	heart	O	B_disease
failure	failure	O	I_disease
after	after	O	O
2	2	O	O
months	months	O	O
of	of	O	O
therapy	therapy	O	O
with	with	O	O
amphotericin	amphotericin	O	O
B	b	O	O
(	(	O	O
AmB	amb	O	O
)	)	O	O
for	for	O	O
disseminated	disseminated	O	O
coccidioidomycosis	coccidioidomycosis	O	S_disease
.	.	O	O

His	his	S_chemicals	O
echocardiographic	echocardiographic	O	O
abnormalities	abnormalities	O	O
and	and	O	O
heart	heart	O	B_disease
failure	failure	O	I_disease
resolved	resolved	O	O
after	after	O	O
posaconazole	posaconazole	O	O
was	was	O	O
substituted	substituted	O	O
for	for	O	O
AmB.	amb.	O	O
It	it	O	O
is	is	O	O
important	important	O	O
to	to	O	O
recognize	recognize	O	O
the	the	O	O
rare	rare	O	O
and	and	O	O
potentially	potentially	O	O
reversible	reversible	O	O
toxicity	toxicity	O	O
of	of	O	O
AmB.	amb.	O	O

